ABATERUSSO, Cataldo
 Distribuzione geografica
Continente #
EU - Europa 1.749
NA - Nord America 1.713
AS - Asia 587
OC - Oceania 5
SA - Sud America 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.062
Nazione #
US - Stati Uniti d'America 1.712
GB - Regno Unito 632
CN - Cina 524
DE - Germania 245
SE - Svezia 219
IE - Irlanda 158
FR - Francia 129
RU - Federazione Russa 121
FI - Finlandia 120
IT - Italia 61
UA - Ucraina 43
SG - Singapore 38
BE - Belgio 13
HK - Hong Kong 6
AU - Australia 5
KR - Corea 5
JP - Giappone 4
BR - Brasile 3
IL - Israele 3
TR - Turchia 3
BD - Bangladesh 2
EG - Egitto 2
ES - Italia 2
NL - Olanda 2
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IN - India 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 4.062
Città #
Southend 592
Jacksonville 478
Woodbridge 194
Chandler 190
Dublin 158
Houston 154
Ann Arbor 146
Ashburn 107
Beijing 76
Wilmington 65
Jinan 62
Lawrence 56
Princeton 56
Nanjing 55
Shenyang 49
Nanchang 36
Hebei 25
Tianjin 25
Haikou 24
Verona 23
Zhengzhou 23
Ningbo 20
Milan 16
Singapore 16
Taizhou 16
Lancaster 15
New York 15
Changsha 14
Brussels 13
Kent 12
Taiyuan 12
Sindelfingen 10
Guangzhou 9
Jiaxing 9
Hangzhou 8
Helsinki 7
Lanzhou 7
Clearwater 6
Norwalk 6
Washington 6
Adelaide 5
Falls Church 5
Seoul 5
Dongguan 4
Düsseldorf 4
Fuzhou 4
Hong Kong 4
Changle 3
Dearborn 3
Detroit 3
Frankfurt am Main 3
London 3
Los Angeles 3
Ypsilanti 3
Bologna 2
Cairo 2
Chicago 2
Chongqing 2
Dolo 2
Osaka 2
Phoenix 2
Qingdao 2
Riva 2
Rome 2
San Diego 2
San Francisco 2
Secaucus 2
São Paulo 2
Tombolo 2
Boardman 1
Briatico 1
Budapest 1
Chaoyang 1
Dhaka 1
Fairfield 1
Falkenstein 1
Fremont 1
Garbagnate Milanese 1
Hanford 1
Jeffries 1
Leawood 1
Legnago 1
Lugano 1
Madrid 1
Manerbio 1
Mehlingen 1
Montréal 1
Mumbai 1
Novokuznetsk 1
Oslo 1
Quito 1
Redmond 1
Rio de Janeiro 1
Seattle 1
Shanghai 1
Shenzhen 1
Tokyo 1
Vienna 1
Yuanping 1
Totale 2.923
Nome #
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. 100
Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. 99
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 98
Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. 93
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. 93
Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy. 93
Giovan Battista Morgagni, a pioneer of clinical nephrology. 93
Effects of cilazapril on Na+ retention and ANP resistance in IDDM hypertensives. 91
Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus. 90
Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms. 90
La nefropatia diabetica 88
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 87
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. 85
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 83
Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. 81
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 81
Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers. 80
Patterns of renal injury in NIDDM patients with microalbuminuria. 79
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 79
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 79
Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. 78
Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans. 78
Water and its effects when drunk cold. The Physician's view (1576-1751). 77
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes. 77
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 77
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 77
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 77
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 76
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 75
Organisation and practice of a kidney register. The Italian View 75
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 75
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine. 74
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 73
General practitioners' serum creatinine recording styles. 72
Unusual renal presentation of Fabry disease in a female patient. 72
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 71
Renal Stones in Medullary Sponge Kidney: Effect of Treatment with Alkali Citrate and Recognition of two Clinical Phenotypes. 70
Guidelines and the myth of Ariadne 69
Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. 66
The nephrologist in the spotlight 63
INSUFFICIENZA RENALE ACUTA DA FARMACI 62
Nephrogenic systemic fibrosis 62
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis. 60
Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. 58
Invecchiamento e funzionalità renale: indagine prospettica in una coorte di soggetti anziani in buone condizioni di salute 57
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? [Review] 57
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. 56
Long-Term Treatment with Potassium Citrate and Renal Stones in Medullary Sponge Kidney. 56
The origin of nephrocalcinosis, Randall's plaque and renal stones: a cell biology viewpoint. 55
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 53
Pathophysiology of hypercalciuria. 52
Restless legs syndrome in kidney patients. 51
[Obesity in dialysis and reverse epidemiology: true or false?] 49
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. 47
Le malattie glomerulari 42
Liver, Kidney and Heart in Obesity: three organs into the same boat (not to mention the fat). 36
Totale 4.087
Categoria #
all - tutte 12.321
article - articoli 10.851
book - libri 0
conference - conferenze 641
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 829
Totale 24.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020579 67 3 2 117 5 77 45 56 6 63 63 75
2020/2021614 98 145 21 90 73 43 0 56 49 3 34 2
2021/2022448 13 175 1 31 48 10 2 24 22 7 34 81
2022/2023786 63 80 113 73 82 232 2 44 71 5 13 8
2023/2024324 15 30 40 32 47 65 5 7 2 14 52 15
Totale 4.087